July 30, 2013
/PRNewswire/ -- Sigma-Aldrich (NASDAQ: SIAL), a leading Life Science and High Technology Company, announced today it has signed an agreement with Paragon Scientific to help develop Paragon's product range and to expand availability of Paragon's calibration standards and certified reference materials through Sigma-Aldrich sales and marketing channels. A new landing page,
, has been established to provide customers with direct access to the full range Paragon products and technical information.
"This agreement strengthens our long standing relationship with Paragon and provides the accredited laboratory community with broader access to essential certified reference materials needed by ISO 17025 accredited laboratories," said Dr.
, Sigma-Aldrich Vice President, Analytical.
Applied Business Unit will be the primary global distribution channel for Paragon Scientific products with Paragon continuing to manage and support its OEM partners and key accounts.
"This agreement will enable scientists around the globe to more easily access Paragon Products. Working together with Sigma-Aldrich, we will be able to develop new certified reference materials to meet the needs of our global customer base," said
, Paragon CEO.
"Using Paragon certified reference materials eliminates potential analytical variables, which ultimately increases confidence in analytical data and could lead to a reduction in time and expense for analysts," said Dr.
, Sigma-Aldrich Business Development Director, Analytical. "In addition, Sigma-Aldrich's web-based marketplace offers convenient access to a comprehensive range of products for the entire analytical workflow."
Paragon recently doubled its research and development capabilities with a move into a newly refurbished facility featuring a suite of purpose designed production laboratories. Production and distribution capacity has also increased three fold.
: The foregoing release contains forward-looking statements that can be identified by terminology such as "to help develop Paragon's product range," "will be able to develop new certified reference materials" or similar expressions, or by expressed or implied discussions regarding potential future revenues from products derived there from. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that this or any other partnership will assist the Company to achieve any particular levels of revenue in the future. In particular, management's expectations regarding future research and development could be affected by, among other things, uncertainties relating to product development; the ability to achieve accreditation; the Company's ability to obtain or maintain patent or other proprietary intellectual property protection; the introduction of competitive products; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Company's assets and liabilities as recorded in its consolidated balance sheet, and other risks and factors referred to in Sigma-Aldrich's current Form 10-K on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Sigma-
is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
: Sigma-Aldrich is a leading Life Science and High Technology company whose biochemical, organic chemical products, kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostics and high technology manufacturing. Sigma-
customers include more than 1.3 million scientists and technologists in life science companies, university and government institutions, hospitals and industry. The Company operates in 38 countries and has nearly 9,000 employees whose objective is to provide excellent service worldwide. Sigma-
is committed to accelerating customer success through innovation and leadership in Life Science and High Technology. For more information about Sigma-Aldrich, please visit its website at
is a registered trademark of Sigma-Aldrich Co. LLC.